Brief: Galectin Therapeutics Reports Qtrly Loss Per Share $0.14
15/11/2021 13:53
Nov 15 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
QUARTER
ENDED SEPTEMBER 30, 2021, AND PROVIDES BUSINESS UPDATE
* QUARTERLY LOSS PER SHARE $0.14
Source text for Eikon: ID:nGNX4yZLz5
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study